Page last updated: 2024-09-05

rpr 104632 and 6,7-dichloroquinoxaline-2,3-dione

rpr 104632 has been researched along with 6,7-dichloroquinoxaline-2,3-dione in 1 studies

Compound Research Comparison

Studies
(rpr 104632)
Trials
(rpr 104632)
Recent Studies (post-2010)
(rpr 104632)
Studies
(6,7-dichloroquinoxaline-2,3-dione)
Trials
(6,7-dichloroquinoxaline-2,3-dione)
Recent Studies (post-2010) (6,7-dichloroquinoxaline-2,3-dione)
5002107

Protein Interaction Comparison

ProteinTaxonomyrpr 104632 (IC50)6,7-dichloroquinoxaline-2,3-dione (IC50)
Glutamate receptor ionotropic, NMDA 2DHomo sapiens (human)0.13
Glutamate receptor ionotropic, NMDA 3BHomo sapiens (human)0.13
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)1.692
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)2.0825
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)2.0825
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)2.0825
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)0.13
Glutamate receptor ionotropic, NMDA 2AHomo sapiens (human)0.13
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)0.13
Glutamate receptor ionotropic, NMDA 2CHomo sapiens (human)0.13
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)2.0825
Glutamate receptor ionotropic, NMDA 3AHomo sapiens (human)0.13
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)2.0825
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)2.0825

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iversen, LL; Leeson, PD1

Reviews

1 review(s) available for rpr 104632 and 6,7-dichloroquinoxaline-2,3-dione

ArticleYear
The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential.
    Journal of medicinal chemistry, 1994, Nov-25, Volume: 37, Issue:24

    Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Binding Sites; Cognition; Glycine; Humans; Kynurenic Acid; Neuroprotective Agents; Pyrrolidinones; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship

1994